Seeking Alpha

Medtronic (MDT -0.2%) says its received FDA clearance for its AIRvance Bone Screw System,...

Medtronic (MDT -0.2%) says its received FDA clearance for its AIRvance Bone Screw System, allowing surgeons to perform a hyoid suspension procedure independently or in combination with other procedures for the treatment of obstructive sleep apnea. Under its previous FDA clearance, the hyoid suspension procedure was indicated as an adjunct to the tongue suspension procedure. With this clearance, the AIRvance System becomes the only approved stand-alone system available.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|